Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 2 mg per 1 mL / 5 mg per 1 mL solution

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Apotex Corp. names for other drugs.

Recalls

• Mar 5, 2026 · Class II · Apotex Corp.
  Lack of Assurance of Sterility
  Lots: Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027
• Sep 5, 2025 · Class II · Apotex Corp.
  Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
  Lots: a) lot # VE0614 exp. date 12/2025 UPC:(01)00360505058914 (5 mL) b) lot # VE0616 exp. date 12/2025 UPC:(01)0(03)60505058921 (10 mL)
• May 28, 2025 · Class II · Apotex Corp.
  Lack of Assurance of Sterility
  Lots: Batch VC6058, Exp Date: 10/31/2025

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Brimonidine and Timolol: every company that makes it

Form

solution, ophthalmic

Strength

2 mg per 1 mL / 5 mg per 1 mL

Approval

ANDA ANDA091442

On the market since

Oct 19, 2022

Package NDCs

60505-0589-1 60505-0589-2 60505-0589-3

Official label

DailyMed (National Library of Medicine), updated Apr 23, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?